GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

German health official: be vigilant, or undo progress we've made

Fri, 26th Feb 2021 09:28

BERLIN, Feb 26 (Reuters) - The head of Germany's RKI health
institute warned the public to be vigilant in upholding social
distancing since there was a risk otherwise of undoing progress
in controlling coronavirus case numbers and triggering a third
wave of the epidemic.

"Alongside the positive developments, we are currently
seeing a few clear signs of the trend turning," Lothar Wieler,
head of the Robert Koch Institute (RKI) for Infectious Diseases,
told a news conference on Friday.

At the joint news conference with Health Minister Jens
Spahn, Wieler also urged Germans not to refuse a vaccine if
offered one. Officials have expressed growing disquiet over the
numbers of doses of the AstraZeneca vaccine being left
untaken by nervous Germans.

(Reporting by Thomas Escritt
Editing by Paul Carrel)

Related Shares

More News
5 Jun 2024 09:52

LONDON BROKER RATINGS: Berenberg raises Taylor Wimpey to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

5 Jun 2024 09:27

AstraZeneca completes USD2.4 billion Fusion Pharmaceuticals purchase

(Alliance News) - AstraZeneca PLC on Wednesday said it successfully completed the acquisition of Boston, Massachusetts-based Fusion Pharmaceuticals In...

3 Jun 2024 08:59

AstraZeneca cancer treatment Tagrisso recommended for approval in EU

(Alliance News) - AstraZeneca PLC said that, following further positive findings in clinical trial, Tagrisso has been recommended for use in the Europ...

3 Jun 2024 07:28

AstraZeneca's lung cancer treatment recommended for approval in EU

(Sharecast News) - AstraZeneca has announced that its Tagrisso treatment for advanced lung cancer, when combined with chemotherapy, has been recommend...

2 Jun 2024 20:03

Astra's Enhertu breast cancer trial shows 'unprecedented' results

June 2 (Reuters) - AstraZeneca and Daiichi Sankyo's Enhertu slows the progression of breast cancer by about five months in women whose disease worse...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.